Autoimmune Disease Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Autoimmune Disease Diagnostics Market By Type (Systemic Autoimmune Disease, Local Autoimmune Disease), By Disease (Diabetes Type-1, Rheumatoid Arthritis, Multiple Sclerosis, Others), By End user (Diagnostic Centers, Hospitals, Research Laboratories, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Autoimmune Disease Diagnostics Market size was valued at USD 4.2 billion in 2021 and is anticipated to grow at USD 6.4 billion till 2028 recording a CAGR of 8.9% during the forecast period 2022-2028. The immune system protects the body from infections and diseases. In autoimmune disorders low or overactivity of immune system may appear. There is no exact cause of autoimmune diseases are identified. In response to unknown trigger, immune system produces antibodies that instead of fighting infections, attacks body own tissues. Autoimmune diseases diagnosed with blood tests and review of disease history, symptoms and physical examination. Rheumatoid arthritis, type-1 diabetes, multiple sclerosis and lupus some of the major autoimmune diseases. Global autoimmune disease diagnostics market is expected to grow at significant rate owing to growing rates of autoimmune diseases. According to National Multiple Sclerosis Society (MS), approximately, 2.3 Mn people are living with multiple sclerosis worldwide. The market is composed of multinational and local companies involved in offering autoimmune diagnostics. Major players are involving in R&D for development and introduction of new diagnostics into the market. Market players are collaborating in order to develop the new diagnostics for the autoimmune diseases and further increasing the market portfolio. For instance, in November 2014, Protagen AG entered into a long-term collaboration with Qiagen to develop an innovative companion diagnostic development platform for autoimmune disorders. Furthermore, government and non-profit organizations are taking initiatives to increase the awareness and involving in development of diagnostics for autoimmune diseases. In November 2016, U.S. FDA has cleared Inova Diagnostic’s assay, “QUANTA LITE Calprotectin Extended Range” to help differentiate inflammatory bowel disease from irritating bowel disease. In November 2014, Adaptive Biotechnologies launched, immunoSEQ, research use only kit for diagnosing autoimmune.

 

Autoimmune Disease Diagnostics Market

MARKET SUMMARY
-
8.9%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 8.9%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Autoimmune Disease Diagnostics Market

  • Autoimmune Disease Diagnostics Market gives historical, current, and future market sizes (US$ Bn) of product type and distribution channel and geographic regions.
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of Infant nutrition
Market Key Players
  • Beckman Coulter, Inc
  • Abbott Laboratories
  • Inova Diagnostics Inc.
  • (Werfen Life Group,
  • Bio-Rad Laboratories
  • Quest Diagnostics Inc.
Autoimmune Disease Diagnostics Market Dynamics

Global market is driven by government initiatives towards increasing awareness in public about autoimmune disorders. In addition, increase in R&D investments and rising prevalence of autoimmune disorders are expected to boost the global autoimmune disease diagnostics market. However, high cost of diagnosis, limited awareness in developing and underdeveloped countries are expected to hinder the market growth. In addition, chances of false results coupled with lack of skilled professionals are expected to hamper the global autoimmune disease diagnostics market over the forecast period.


North-America Got Significant Share

Autoimmune Disease Diagnostics Market

Geographically, global market is segmented into following regions, viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to be major market for autoimmune disease diagnostics owing to increase in prevalence of autoimmune disorders, presence of many market players, and government initiatives to promote the autoimmune disease awareness. Europe is expected to expand at significant growth rate for global autoimmune disease diagnostics due to growing awareness and rising prevalence of autoimmune diseases. Asia-Pacific is expected to grow at faster rates owing to expansion of MNC’s into the developing countries of the region such as India.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Autoimmune Disease Diagnostics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Table of Content
2. Executive Summary
3. Global Autoimmune Disease Diagnostics Market Introduction
3.1. Global Autoimmune Disease Diagnostics Market – Taxonomy
3.2. Global Autoimmune Disease Diagnostics Market –Definitions
3.2.1. Type
3.2.2. Disease
3.2.3. End User
4. Global Autoimmune Disease Diagnostics Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
4.5. Global Autoimmune Disease Diagnostics Market Dynamic Factors – Impact Analysis
4.6. Global Autoimmune Disease Diagnostics Market – Competition Landscape
4.7. Epidemiology
5. Global Autoimmune Disease Diagnostics Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
5.3. Market OpportunityAnalysis
6. Global Autoimmune Disease Diagnostics Market, By Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1. Systemic Autoimmune Disease
6.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Local Autoimmune Disease
6.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Autoimmune Disease Diagnostics Market Forecast, By Disease,2015 – 2019 and Forecast, 2020 – 2026
7.1. Diabetes Type-1
7.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Rheumatoid Arthritis
7.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Multiple Sclerosis
7.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Autoimmune Disease Diagnostics Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.1. Diagnostic Centers
8.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals
8.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Research Laboratories
8.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Autoimmune Disease Diagnostics Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Autoimmune Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Disease, By End User and Region, 2020 – 2026
10. North America Autoimmune Disease Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Systemic Autoimmune Disease
10.1.2. Local Autoimmune Disease
10.2. Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Diabetes Type-1
10.2.2. Rheumatoid Arthritis
10.2.3. Multiple Sclerosis
10.2.4. Others
10.3. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Diagnostic Centers
10.3.2. Hospitals
10.3.3. Research Laboratories
10.3.4. Others
10.4. Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. U.S.
10.4.2. Canada
10.5. North America Autoimmune Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
10.6. North America Autoimmune Disease Diagnostics Market Dynamics – Trends
11. Europe Autoimmune Disease Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
11.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Systemic Autoimmune Disease
11.1.2. Local Autoimmune Disease
11.2. Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Diabetes Type-1
11.2.2. Rheumatoid Arthritis
11.2.3. Multiple Sclerosis
11.2.4. Others
11.3. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Diagnostic Centers
11.3.2. Hospitals
11.3.3. Research Laboratories
11.3.4. Others
11.4. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Germany
11.4.2. UK
11.4.3. France
11.4.4. Spain
11.4.5. Italy
11.4.6. Russia
11.4.7. Poland
11.4.8. Rest of Europe
11.5. Europe Autoimmune Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
11.6. Europe Autoimmune Disease Diagnostics Market Dynamics – Trends
12. Asia-Pacific Autoimmune Disease Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
12.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Systemic Autoimmune Disease
12.1.2. Local Autoimmune Disease
12.2. Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Diabetes Type-1
12.2.2. Rheumatoid Arthritis
12.2.3. Multiple Sclerosis
12.2.4. Others
12.3. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Diagnostic Centers
12.3.2. Hospitals
12.3.3. Research Laboratories
12.3.4. Others
12.4. Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. ASEAN
12.4.5. Australia & New Zealand
12.4.6. Rest of Asia-Pacific
12.5. Asia-Pacific Autoimmune Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
12.6. Asia-Pacific Autoimmune Disease Diagnostics Market Dynamics – Trends
13. Latin America Autoimmune Disease Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
13.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Systemic Autoimmune Disease
13.1.2. Local Autoimmune Disease
13.2. Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Diabetes Type-1
13.2.2. Rheumatoid Arthritis
13.2.3. Multiple Sclerosis
13.2.4. Others
13.3. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Diagnostic Centers
13.3.2. Hospitals
13.3.3. Research Laboratories
13.3.4. Others
13.4. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Argentina
13.4.4. Venezuela
13.4.5. Rest of Latin America
13.5. Latin America Autoimmune Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
13.6. Latin America Autoimmune Disease Diagnostics Market Dynamics – Trends
14. Middle East and Africa Autoimmune Disease Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
14.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Systemic Autoimmune Disease
14.1.2. Local Autoimmune Disease
14.2. Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Diabetes Type-1
14.2.2. Rheumatoid Arthritis
14.2.3. Multiple Sclerosis
14.2.4. Others
14.3. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Diagnostic Centers
14.3.2. Hospitals
14.3.3. Research Laboratories
14.3.4. Others
14.4. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.4.1. Gulf Cooperation Council (GCC) Countries
14.4.2. Israel
14.4.3. South Africa
14.4.4. Rest of MEA
14.5. MEA Autoimmune Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
14.6. MEA Autoimmune Disease Diagnostics Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Beckman Coulter, Inc. (U.S.)
15.2.2. Abbott Laboratories (U.S.)
15.2.3. F. Hoffmann-La Roche Ltd. (Switzerland)
15.2.4. bioMerieux SA (France)
15.2.5. Siemens AG (Siemens Healthineers) (Germany)
15.2.6. Inova Diagnostics Inc. (Werfen Life Group, S.A.(Spain)
15.2.7. Bio-Rad Laboratories (U.S.)
15.2.8. MBL International Corporation (U.S.)
15.2.9. Quest Diagnostics Inc. (U.S.).
16. Research Methodology
17. Key Assumptions and Acronyms

18. Disclaimer
19. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.


Report

Company Profile

  • Beckman Coulter, Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • BioMerieux S.A. (France)
  • Siemens AG (Siemens Healthineers) (Germany)
  • Inova Diagnostics Inc. (Werfen Life Group, S.A.(Spain)
  • Bio-Rad Laboratories (U.S.)
  • MBL International Corporation (U.S.)
  • Quest Diagnostics Inc. (U.S.)

Description

Autoimmune Disease Diagnostics Market size was valued at USD 4.2 billion in 2021 and is anticipated to grow at USD 6.4 billion till 2028 recording a CAGR of 8.9% during the forecast period 2022-2028. The immune system protects the body from infections and diseases. In autoimmune disorders low or overactivity of immune system may appear. There is no exact cause of autoimmune diseases are identified. In response to unknown trigger, immune system produces antibodies that instead of fighting infections, attacks body own tissues. Autoimmune diseases diagnosed with blood tests and review of disease history, symptoms and physical examination. Rheumatoid arthritis, type-1 diabetes, multiple sclerosis and lupus some of the major autoimmune diseases. Global autoimmune disease diagnostics market is expected to grow at significant rate owing to growing rates of autoimmune diseases. According to National Multiple Sclerosis Society (MS), approximately, 2.3 Mn people are living with multiple sclerosis worldwide. The market is composed of multinational and local companies involved in offering autoimmune diagnostics. Major players are involving in R&D for development and introduction of new diagnostics into the market. Market players are collaborating in order to develop the new diagnostics for the autoimmune diseases and further increasing the market portfolio. For instance, in November 2014, Protagen AG entered into a long-term collaboration with Qiagen to develop an innovative companion diagnostic development platform for autoimmune disorders. Furthermore, government and non-profit organizations are taking initiatives to increase the awareness and involving in development of diagnostics for autoimmune diseases. In November 2016, U.S. FDA has cleared Inova Diagnostic’s assay, “QUANTA LITE Calprotectin Extended Range” to help differentiate inflammatory bowel disease from irritating bowel disease. In November 2014, Adaptive Biotechnologies launched, immunoSEQ, research use only kit for diagnosing autoimmune.

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX